Phase III North American Clinical Trial for COVID-19 Treatment begins.

Jean_Bourbeau_image

Dr. Jean Bourbeau, Director, Centre for Innovative Medicine, RI- MUHC

Format

JPEG

Source

MUHC Foundation

Téléchargements